Clinical Trial Update: A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating pharmacologic ascorbate and ferumoxytol in addition to standard-of-care chemoradiation for glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)
• Pharmacologic ascorbate (ascorbic acid)

Snippet

Sponsor: Bryan Allen | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 1 | Status: ACTIVE_NOT_RECRUITING